TABLE 6.

Reactivity of every single recombinant antigens in the IgG line blot assay

GroupaNo. of seraNo. (%) of sera reactive with:
DbpAp41iOspCVlsEBmpAp58 PBiP100 PKo
PBibPBrPKoB31bPBiPKo20047PBiPKoB31PBibPKobPKa2PBiPKoB31
EM150 (0.0)2 (13.3)4 (26.7)1 (6.7)0 (0.0)1 (6.7)3 (20.0)1 (6.7)1 (6.7)1 (6.7)12 (80.0)9 (60.0)6 (40.0)0 (0.0)1 (6.7)1 (6.7)1 (6.7)4 (26.7)
NB5019 (38.0)20 (40.0)17 (34.0)6 (12.0)6 (12.0)15 (30.0)5 (10.0)2 (4.0)4 (8.0)8 (16.0)44 (88.0)41 (82.0)41 (82.0)17 (34.0)12 (24.0)13 (26.0)27 (54.0)26 (52.0)
ACA101 (10.0)0 (0.0)8 (80.0)1 (10.0)3 (30.0)9 (90.0)0 (0.0)1 (10.0)3 (30.0)0 (0.0)10 (100.0)0 (0.0)10 (100.0)1 (10.0)1 (10.0)0 (0.0)10 (100.0)8 (80.0)
AT107 (70.0)1 (10.0)9 (90.0)2 (20.0)5 (50.0)8 (80.0)4 (40.0)1 (10.0)5 (50.0)3 (30.0)10 (100.0)2 (20.0)9 (90.0)5 (50.0)2 (20.0)4 (40.0)9 (90.0)9 (90.0)
Controls1102 (1.8)2 (1.8)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)1 (0.9)3 (2.7)0 (0.0)0 (0.0)0 (0.0)0 (0.0)1 (0.9)2 (1.8)
  • a For abbreviations, see Table 2, footnote a.

  • b Additional antigen on the IgG line blot assay.